Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here ...

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

As life returns to normal following the global disruptions caused by Covid-19, its long-term health effects have started ...

Bruce Springsteen and the E Street Band” and Billy Crystal starring in a new series for Apple TV+ called “Before” are some of ...

Number 5: The FDA has approved Imuldosa (ustekinumab-srlf), a biosimilar referencing Stelara (ustekinumab), for the treatment ...

2 Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China 3 University of Chinese Academy of Sciences, Beijing, ...

Analyst Julian Harrison of BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of ...

HC Wainwright has initiated coverage on Alumis, highlighting the biopharmaceutical company's lead drug candidate, ESK-001.

We recently published a list of 8 High Growth UK Stocks to Invest In. In this article, we are going to take a look at where ...

The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...